Medicare To Track Transfusions In Dialysis Patients To Ensure Appropriate ESA Use
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS proposes to monitor transfusions in patients with end-stage renal disease as a new Medicare quality measure aimed at ensuring erythropoiesis-stimulating agents like Amgen’s Epogen are not “underutilized.”